Pioneering personalized medicine research in human gene correction, mitochondrial replacement therapy (MRT), human embryonic stem cells (hESC), induced pluripotent stem cells (iPS) & somatic cell nuclear transfer (SCNT) Support our Lab
In the News
Science News editors have identified "CRISPR gene editing moves into humans, spurs debate" as their Number 2 story of 2017. OHSU scientists Shoukhrat Mitalipov and Paula Amato's CRISPR research was one of @ScienceNews' top stories of 2017! #SNTop10
Mitalipov successfully repairs genes in human embryos
A ground breaking discovery by Shoukhrat Mitalipov, Ph.D., was reported in Nature —the successful removal of a lethal genetic defect in human embryos. The breakthrough is the initial confirmation that a dangerous genetic defect can in theory be erased.
New research provides key insight about mitochondrial replacement therapy
A new discovery may unlock the answer to a vexing scientific question: How to conduct mitochondrial replacement therapy, a new gene-therapy technique, in such a way that safely prevents the transmission of harmful mitochondrial gene mutations from mothers to their children.
New Technique could increase success of infertility treatment
Families struggling with infertility or a genetic predisposition for debilitating mitochondrial diseases may someday benefit from a new breakthrough led by scientists at OHSU and the Salk Institute for Biological Studies.